Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why

Analyst Upgrades03:32

Express News | Vir Biotechnology Inc : Morgan Stanley Raises to Overweight From Equal-Weight

BreakingsJan 10 23:51

Morgan Stanley Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $20

Futu NewsJan 10 22:31 · Ratings

Morgan Stanley Upgrades Vir Biotechnology(VIR.US) to Buy Rating, Raises Target Price to $20

Futu NewsJan 10 19:34 · Ratings

Barclays Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $26

Futu NewsJan 10 19:34 · Ratings

H.C. Wainwright Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $110

Futu NewsJan 10 19:34 · Ratings